doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: english

1 - 5 of 9 <<previous | next>>

Diseases results:

Leprosy

Articles results:

Washington, D.C., To Offer Caremark Rx Discount Cards To All Residents
Washington, D.C., Mayor Anthony Williams on Wednesday announced a program called DC Rx that will provide prescription drug discount cards at no cost to residents, the Washington Post reports (Silverman, Washington Post, 10/19). The cards, which will be accepted at 98% of D.C.


Takeda Announces Termination Of License Agreement For Tavocept(TM) In Japan
ASKA Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Company Limited announced the termination of the License Agreement of March 15, 2006 that had previously been entered into by Takeda, ASKA, KI Pharmaceuticals, Inc.(*) and BioNumerik Pharmaceuticals, Inc. with respect to the investigational new drug known as Tavocept(TM) for the territory of Japan.


Wiley Acquires HEED, The World's Leading Health Economic Evaluations Database
John Wiley & Sons, Ltd., announced on 15-Nov-2006 that it has completed the acquisition of Health Economic Evaluations Database (HEED), an online source of health economic information and evaluations.HEED was developed as a joint initiative between the Office of Health Economics (OHE) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).


UCSF Pharmacy School Receives Major Grant From Amgen Foundation For Medicare Part D Outreach
The UCSF School of Pharmacy has received a $3.7 million grant from the Amgen Foundation to fund an innovative program that will help underserved elderly Californians learn about and select from Medicare prescription drug plans. There currently are more than 70 of these drug plans in the state, most of which are Medicare Part D plans.


High Drug Costs Could Jeopardize Brazil's No-Cost Antiretroviral Program
The rising cost of new antiretroviral drugs could jeopardize Brazil's program that provides the drugs to HIV-positive people in the country at no cost, the Boston Globe reports.




1 - 5 of 9 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.